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Pharmaceutical regulatory agencies increasingly require the implementation of systematic approaches 
covering the entire life-cycle of pharmaceutical products, from manufacturing processes to quality control tests. 
In 2009, the International Council for Harmonisation (ICH) of technical requirements for pharmaceuticals for 
human use proposed a systematic approach named “Quality by Design” (QbD) to be implemented in the 
pharmaceutical field [1]. In this context, the QbD strategy have been progressively applied also to other aspects 
of the pharmaceutical chain, such as the analytical method development in quality control laboratories. The QbD 
applied to analytical chemistry is commonly named “Analytical Quality by Design” (AQbD) and in the last 
decade it has been widely applied in academia for the development of separation methods, involving different 
techniques such as LC, CE as well as SFC. However, its implementation in quality control laboratories still 
remains limited and then its advantages not completely exploited. Indeed, this approach presents a lot of 
conveniences, such as the deep knowledge acquired during the method development/optimisation by studying 
how critical method parameters (CMPs) affect critical method attributes (CMAs). Moreover, this strategy allows 
the possibility to define a method operable design region (MODR) consisting of a multitude of possible working 
points and for each of them a specific probability of success (π) is given. Indeed, the concept of risk plays a 
central role in this strategy as the MODR is considered of a zone of theoretical robustness limited by the so-
called edges of failure, outside which the method performances are not accepted [2]. This presentation focuses 
first on the theoretical aspects regarding each step of this strategy. The analytical target profile definition, the 
selection of CMPs and CMAs, as well as screening and optimisation of CMPs and MODR definition are 
accurately described and illustrated. Some considerations about the choice of the working point, its validation 
and the planning of an efficient control strategy are also given. In the second part of this presentation all these 
concepts are once again showcased but from a practical point of view, by giving two concrete case-studies 
following the AQbD approach. The first one concerns the development of a liquid chromatography coupled to 
UV (LC-UV) method aimed at quantifying the cannabinoids content in cannabis extracts used for medicinal 
purposes [3]. The second one shows the approach applied to the development of a stability indicating method by 
using another analytical technique, the supercritical-fluid-chromatography coupled to mass spectrometry (SFC-
MS). This latter is intended to be used for the quantification of hydro-soluble vitamins and amino acids in a 
complex medium.  
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